Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Identifying common mistakes in retirement planning can save you from future pitfalls. Learn what to avoid for a secure retirement.
14,327 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Investors seek steady income with limited risk. This guide compares Vanguard Short-Term Bond ETF and Schwab Short-Ter...
A coalition representing the crypto industry files a lawsuit to block Illinois' Digital Asset Tax Act, arguing the le...
Machi Big Brother’s high-stakes run appears to be nearing an end as his Hyperliquid balance drops below $1 million. T...
Data centers are growing fast, driven by cloud and AI. The real engine? Utilities expanding power capacity and reliab...
Brad Reese, heir to the Reese’s legacy, alleges Hershey’s has shifted core ingredients in Reese’s cups. Hershey says ...
As earnings season arrives, praxis medicines 2025 earnings offer a compelling snapshot of where the company stands. T...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Delta expects halt flights at NYC and Boston hubs as a blizzard bears down on the Northeast, disrupting travel plans ...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...